jueves, 25 de octubre de 2018

9 things to know about Alkermes and its controversial drug for depression - STAT

9 things to know about Alkermes and its controversial drug for depression - STAT

Daily Recap





STAT Plus: 9 things to know about Alkermes and its controversial drug for treatment-resistant depression

By ADAM FEUERSTEIN


APSTOCK
The FDA is bringing together a panel of outside experts to review a novel and controversial drug for treatment-resistant depression.



No hay comentarios:

Publicar un comentario